John W. Rogers Jr. - Ariel Appreciation Fund 13F Activity & Position Changes (Q3 2021)

According to the SEC 13F filed on Nov 12, 2021, the Ariel Appreciation Fund portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2021. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2021, the filing reported:

New Buys - Boyd Gaming Corporation, Gentex Corporation, Manchester United, Resideo Technologies, Inc., Vanguard FTSE All World Ex US E, and 1 more

Increases - ADT Inc., AFLAC Incorporated, Affiliated Managers Group, Inc., APA Corporation, Adtalem Global Education Inc., and 50 more

Reductions - Astrazeneca PLC, Bio-Rad Laboratories, Inc., The Bank of New York Mellon Cor, Berkshire Hathaway Inc. New, Banco Santander - Chile, and 30 more

Complete Exits - Cumberland Pharmaceuticals Inc., GSI Technology, Inc., Matthews International Corporat, 180 Degree Capital Corp.

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q3 2021	ADT ADT Inc.	ADT Inc.	Buy	+8,973,442	+58.6%	$196.48K	24,287,261
Q3 2021	AFL AFLAC Incorporated	AFLAC Incorporated	Buy	+61,658	+4.2%	$80.14K	1,537,344
Q3 2021	AMG Affiliated Managers Group, Inc.	Affiliated Managers Group, Inc.	Buy	+15,330	+1.9%	$127.34K	842,809
Q3 2021	APA APA Corporation	APA Corporation	Buy	+93,431	+21.1%	$11.49K	536,115
Q3 2021	ATGE Adtalem Global Education Inc.	Adtalem Global Education Inc.	Buy	+352,447	+10.5%	$140.46K	3,714,781
Q3 2021	AXTA Axalta	Axalta	Buy	+172,859	+3.1%	$167.92K	5,752,561
Q3 2021	AZN Astrazeneca PLC	Astrazeneca PLC	Sell	-75	-0.3%	$1.58K	26,347
Q3 2021	BAP Credicorp	Credicorp	Buy	+497,508	+65.2%	$139.85K	1,260,629
Q3 2021	BCO Brinks Company (The)	Brinks Company (The)	Buy	+230,172	+13.2%	$124.57K	1,967,891
Q3 2021	BIDU Baidu, Inc.	Baidu, Inc.	Buy	+284,745	+12.3%	$399.82K	2,600,474
Q3 2021	BIO Bio-Rad Laboratories, Inc.	Bio-Rad Laboratories, Inc.	Sell	-194	-0.4%	$38.74K	51,940
Q3 2021	BK The Bank of New York Mellon Cor	The Bank of New York Mellon Cor	Sell	-1,194	-0.9%	$6.77K	130,534
Q3 2021	BMY Bristol-Myers Squibb Company	Bristol-Myers Squibb Company	Buy	+279,410	+48.7%	$50.49K	853,389
Q3 2021	BOKF BOK Financial Corporation	BOK Financial Corporation	Buy	+172,797	+5.5%	$294.49K	3,288,569
Q3 2021	BRC Brady Corporation	Brady Corporation	Buy	+17,690	+3.1%	$29.92K	590,222
Q3 2021	BRK-B Berkshire Hathaway Inc. New	Berkshire Hathaway Inc. New	Sell	-73,834	-19.6%	$82.91K	303,759
Q3 2021	BSAC Banco Santander - Chile	Banco Santander - Chile	Sell	-172,325	-13.9%	$21.15K	1,069,683
Q3 2021	BWA BorgWarner Inc.	BorgWarner Inc.	Buy	+157,593	+10.0%	$74.60K	1,726,354
Q3 2021	BYD Boyd Gaming Corporation	Boyd Gaming Corporation	Buy - Position Entry	+138,984	-	$8.79K	138,984
Q3 2021	CAH Cardinal Health, Inc.	Cardinal Health, Inc.	Buy	+43,158	+4.2%	$53.33K	1,078,191
Q3 2021	CBRE CBRE Group Inc	CBRE Group Inc	Buy	+13,006	+0.8%	$160.37K	1,647,142
Q3 2021	CHKP Check Point	Check Point	Buy	+2,573	+0.5%	$53.52K	473,462
Q3 2021	CPIX Cumberland Pharmaceuticals Inc.	Cumberland Pharmaceuticals Inc.	Sell - Position Exit	-12,033	-100.0%	$0.00	-
Q3 2021	CRL Charles River Laboratories Inte	Charles River Laboratories Inte	Sell	-37,894	-17.1%	$75.60K	183,205
Q3 2021	EQC Equity	Equity	Buy	+122,564	+8.9%	$38.97K	1,500,061
Q3 2021	EVR Evercore Inc.	Evercore Inc.	Sell	-18,848	-7.3%	$32.00K	239,398
Q3 2021	FAF First American Corporation (New	First American Corporation (New	Sell	-143,993	-2.7%	$353.12K	5,266,471
Q3 2021	G02602103 Amdocs	Amdocs	Buy	+45,111	+5.2%	$69.36K	916,135
Q3 2021	GILD Gilead Sciences, Inc.	Gilead Sciences, Inc.	Buy	+120,097	+4.8%	$183.00K	2,619,896
Q3 2021	GNTX Gentex Corporation	Gentex Corporation	Buy - Position Entry	+3,256,045	-	$107.38K	3,256,045

Page 1 of 4